User loginPrimary Links
|
ContactVaccination News Sandy Gottstein, President P.O Box 111818 Anchorage, Alaska 99511-1818 United States of America If you have any problems with the site please contact webmaster@vaccinationnews.com
|
"A foolish faith in authority is the worst enemy of truth." -- Albert Einstein, letter to a friend, 1901 "I know of no safe depository of the ultimate powers of the society but the people themselves, and if we think them not enlightened enough to exercise control with a wholesome discretion, the remedy is not to take it from them, but to inform their discretion by education." -- Thomas Jefferson, letter to William C. Jarvis, September 28, 1820 Sandy's Scandals ColumnPicks of the Day SamplesFor the full Picks of the Day Sample click HERE * ►April 20, 2010 - Infection Prevention in a Large Community-Wide Drive-Thru Point of Dispensing (POD) for H1N1 Pandemic Influenza Immunization - 44th National Immunization Conference (NIC) (abstract) - "On November 11-12, 2009 a community-wide H1N1 immunization point of dispensing (POD) was held at a large stadium parking lot. ...During those two days, a total of 19,079 vaccines were administered with 12,613 (66.1%) being administered via a ten lane drive-thru. Specific infection prevention issues were anticipated including 1) vaccine handling, 2) injection site skin disinfection, 3) hand hygiene, 4) environmental disinfection, 5) needle safety, and 6) occupational exposure management." * ►April 2010 - Vaccination, squalene and anti-squalene antibodies: Facts or fiction? - journal article (European Journal of Internal Medicine) - "Nearly a decade ago, squalene was supposed to be the experimental anthrax vaccine ingredient that caused the onset of Persian Gulf War syndrome in many veterans, since antibodies to squalene were detected in the blood of most patients affected by this syndrome. This evidence has raised a widespread concern about the safety of squalene containing adjuvants (especially MF59) of influenza vaccines. Nevertheless, further clinical evidence clearly suggested that squalene is poorly immunogenic, that low titres of antibodies to squalene can be also detected in sera from healthy individuals, and that neither the presence of anti-squalene antibodies nor their titre is significantly increased by immunization with vaccines containing squalene (or MF59) as an adjuvant. This review summarizes the current scientific evidence about the relationship between squalene, anti-squalene antibodies and vaccination." * ►March 12, 2010 - Human Papillomavirus (HPV) - Quadrivalent & Bivalent Vaccines Global Parental Concerns Regarding Safety and Efficacy of Gardasil & Cervarix - FDA Webinar (pdf) - Truth About Gardasil * ►March 12, 2010 - These are the supporting documents from the webinar presented to the Food and Drug Administration ( FDA ) on March 12,2010. - The Truth About Gardasil |
